ACCESS-Leukemia for Adults with Acute Leukemia or MDS
This study, called ACCESS-Leukemia, is looking at how screening for health-related social needs and early social work help might benefit adults with acute leukemia or a type of myelodysplastic syndrome (MDS). These social needs, like financial hardship or housing issues, can impact health. Researchers want to see if this intervention, which includes a survey about your social needs and a social work consultation, is practical and helpful. They will compare this approach to standard care. The study aims to understand if this early support can improve outcomes for patients. You may be able to join if you are an adult (18 or older) newly referred to an outpatient adult leukemia treatment program with certain diagnoses of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL), or intermediate/high-risk MDS.
- Study design
- This is an interventional study with a planned enrollment of 80 participants. It compares a social needs screening and social work consultation to usual care.
- What's involved
- You would complete a screening survey about your health-related social needs and have a social work consultation within two weeks of joining. You will also complete baseline assessments.
- Compensation
- Not stated in the trial record.
- Follow-up
- The study measures outcomes like enrollment rates, survey completion, and intervention acceptability for up to 24 weeks.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Addressing Cancer Care Equity With Social Determinants of Health Screening and Early Intervention
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Michelle H Lee, MD · PRINCIPAL_INVESTIGATOR · Mass General Brigham Cancer Institute
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Rate of eligible participants enrolling24 weeks
Number of participants that are eligible to enroll on the protocol
- Rate of HRSN survey completion24 weeks
Number of participants that complete the HRSN screen before 3rd leukemia clinic visit from time of study enrollment
- Acceptability of interventionup to week 24
Satisfaction rating of participants who received the intervention on the Client Satisfaction Questionnaire (CSQ). The CSQ includes 4 questions and is scored on a 4-point Likert scale with higher score indicating higher satisfaction. The program will be deemed acceptable if mean average score of participants is 12 or higher (out of 16).